BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 7702577)

  • 1. Identification and characterization of the type-IVA cyclic AMP-specific phosphodiesterase RD1 as a membrane-bound protein expressed in cerebellum.
    Shakur Y; Wilson M; Pooley L; Lobban M; Griffiths SL; Campbell AM; Beattie J; Daly C; Houslay MD
    Biochem J; 1995 Mar; 306 ( Pt 3)(Pt 3):801-9. PubMed ID: 7702577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification, characterization and regional distribution in brain of RPDE-6 (RNPDE4A5), a novel splice variant of the PDE4A cyclic AMP phosphodiesterase family.
    McPhee I; Pooley L; Lobban M; Bolger G; Houslay MD
    Biochem J; 1995 Sep; 310 ( Pt 3)(Pt 3):965-74. PubMed ID: 7575434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineered deletion of the unique N-terminal domain of the cyclic AMP-specific phosphodiesterase RD1 prevents plasma membrane association and the attainment of enhanced thermostability without altering its sensitivity to inhibition by rolipram.
    Shakur Y; Pryde JG; Houslay MD
    Biochem J; 1993 Jun; 292 ( Pt 3)(Pt 3):677-86. PubMed ID: 7686364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracellular localization of the PDE4A cAMP-specific phosphodiesterase splice variant RD1 (RNPDE4A1A) in stably transfected human thyroid carcinoma FTC cell lines.
    Pooley L; Shakur Y; Rena G; Houslay MD
    Biochem J; 1997 Jan; 321 ( Pt 1)(Pt 1):177-85. PubMed ID: 9003417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chimeric constructs show that the unique N-terminal domain of the cyclic AMP phosphodiesterase RD1 (RNPDE4A1A; rPDE-IVA1) can confer membrane association upon the normally cytosolic protein chloramphenicol acetyltransferase.
    Scotland G; Houslay MD
    Biochem J; 1995 Jun; 308 ( Pt 2)(Pt 2):673-81. PubMed ID: 7772057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The SH3 domain of Src tyrosyl protein kinase interacts with the N-terminal splice region of the PDE4A cAMP-specific phosphodiesterase RPDE-6 (RNPDE4A5).
    O'Connell JC; McCallum JF; McPhee I; Wakefield J; Houslay ES; Wishart W; Bolger G; Frame M; Houslay MD
    Biochem J; 1996 Aug; 318 ( Pt 1)(Pt 1):255-61. PubMed ID: 8761480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular cloning and transient expression in COS7 cells of a novel human PDE4B cAMP-specific phosphodiesterase, HSPDE4B3.
    Huston E; Lumb S; Russell A; Catterall C; Ross AH; Steele MR; Bolger GB; Perry MJ; Owens RJ; Houslay MD
    Biochem J; 1997 Dec; 328 ( Pt 2)(Pt 2):549-58. PubMed ID: 9371714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of two splice variant forms of type-IVB cyclic AMP phosphodiesterase, DPD (rPDE-IVB1) and PDE-4 (rPDE-IVB2) in brain: selective localization in membrane and cytosolic compartments and differential expression in various brain regions.
    Lobban M; Shakur Y; Beattie J; Houslay MD
    Biochem J; 1994 Dec; 304 ( Pt 2)(Pt 2):399-406. PubMed ID: 7998974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification, characterization and analysis of rolipram inhibition of a human type-IVA cyclic AMP-specific phosphodiesterase expressed in yeast.
    Wilson M; Sullivan M; Brown N; Houslay MD
    Biochem J; 1994 Dec; 304 ( Pt 2)(Pt 2):407-15. PubMed ID: 7528009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The human cyclic AMP-specific phosphodiesterase PDE-46 (HSPDE4A4B) expressed in transfected COS7 cells occurs as both particulate and cytosolic species that exhibit distinct kinetics of inhibition by the antidepressant rolipram.
    Huston E; Pooley L; Julien P; Scotland G; McPhee I; Sullivan M; Bolger G; Houslay MD
    J Biol Chem; 1996 Dec; 271(49):31334-44. PubMed ID: 8940140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphodiesterase 4 in macrophages: relationship between cAMP accumulation, suppression of cAMP hydrolysis and inhibition of [3H]R-(-)-rolipram binding by selective inhibitors.
    Kelly JJ; Barnes PJ; Giembycz MA
    Biochem J; 1996 Sep; 318 ( Pt 2)(Pt 2):425-36. PubMed ID: 8809029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular cloning and expression, in both COS-1 cells and S. cerevisiae, of a human cytosolic type-IVA, cyclic AMP specific phosphodiesterase (hPDE-IVA-h6.1).
    Sullivan M; Egerton M; Shakur Y; Marquardsen A; Houslay MD
    Cell Signal; 1994 Sep; 6(7):793-812. PubMed ID: 7888306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of phosphodiesterase 4 in guinea-pig macrophages: multiple activities, association states and sensitivity to selective inhibitors.
    Kelly JJ; Barnes PJ; Giembycz MA
    Br J Pharmacol; 1998 May; 124(1):129-40. PubMed ID: 9630352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alternative splicing of cAMP-specific phosphodiesterase mRNA transcripts. Characterization of a novel tissue-specific isoform, RNPDE4A8.
    Bolger GB; McPhee I; Houslay MD
    J Biol Chem; 1996 Jan; 271(2):1065-71. PubMed ID: 8557632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and characterization of the human homologue of the short PDE4A cAMP-specific phosphodiesterase RD1 (PDE4A1) by analysis of the human HSPDE4A gene locus located at chromosome 19p13.2.
    Sullivan M; Rena G; Begg F; Gordon L; Olsen AS; Houslay MD
    Biochem J; 1998 Aug; 333 ( Pt 3)(Pt 3):693-703. PubMed ID: 9677330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human phosphodiesterase 4A: characterization of full-length and truncated enzymes expressed in COS cells.
    Owens RJ; Catterall C; Batty D; Jappy J; Russell A; Smith B; O'Connell J; Perry MJ
    Biochem J; 1997 Aug; 326 ( Pt 1)(Pt 1):53-60. PubMed ID: 9337850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of five different proteins produced by alternatively spliced mRNAs from the human cAMP-specific phosphodiesterase PDE4D gene.
    Bolger GB; Erdogan S; Jones RE; Loughney K; Scotland G; Hoffmann R; Wilkinson I; Farrell C; Houslay MD
    Biochem J; 1997 Dec; 328 ( Pt 2)(Pt 2):539-48. PubMed ID: 9371713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mapping the functional domains of human recombinant phosphodiesterase 4A: structural requirements for catalytic activity and rolipram binding.
    Jacobitz S; McLaughlin MM; Livi GP; Burman M; Torphy TJ
    Mol Pharmacol; 1996 Oct; 50(4):891-9. PubMed ID: 8863835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of Ca2+/calmodulin-stimulated cyclic AMP phosphodiesterase (PDE1) activity in Chinese hamster ovary cells (CHO) by phorbol 12-myristate 13-acetate and by the selective overexpression of protein kinase C isoforms.
    Spence S; Rena G; Sweeney G; Houslay MD
    Biochem J; 1995 Sep; 310 ( Pt 3)(Pt 3):975-82. PubMed ID: 7575435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of conserved histidines in catalytic activity and inhibitor binding of human recombinant phosphodiesterase 4A.
    Jacobitz S; Ryan MD; McLaughlin MM; Livi GP; DeWolf WE; Torphy TJ
    Mol Pharmacol; 1997 Jun; 51(6):999-1006. PubMed ID: 9187266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.